Bachelorarbeit, 2024
41 Seiten, Note: 9
1. Introduction
1.1. Overview of the significance of predicting drug-target interactions
1.2. Challenges in the traditional drug discovery methods
1.3. The role of machine learning in accelerating drug discovery
1.4. Objectives
2. Literature Review
2.1. Defining drug-target interactions and their importance in pharmacology
2.2. The traditional methods used for identifying drug-target interactions
2.3. The limitations of these methods and the need for computational approaches
2.4. Overview of machine learning techniques/algorithms
3. Data Collection and Preprocessing
3.1. Describing the sources of data
3.2. The process of data preprocessing
3.3. Challenges encountered during data collection and preprocessing
4. Machine Learning Models
4.1. Presenting important algorithms used for predicting drug-target interactions, such as:
4.1.1. Support Vector Machines
4.1.2. Random Forest
4.1.3. Neural Networks
4.2. The principles behind each algorithm and their suitability
5. Evaluation Metrics
5.1. The metrics used to evaluate the performance of the machine learning models and how these metrics measure the accuracy, precision, recall, and other relevant aspects of the predictions
6. Experimental Setup
6.1. Describe the experimental setup used for training, validation, and testing the machine learning models
6.2. Specifying the parameters chosen for each model
7. Results
7.1. Presenting the environment setup and results of the experiment
8. Future Directions
8.1. Proposing Future Research Directions
9. Conclusion
This research aims to evaluate the effectiveness of various machine learning models in predicting drug-target interactions (DTIs) to streamline the drug discovery process and foster innovation in pharmaceutical research.
3.3. Challenges encountered during data collection and preprocessing
Data collection and preprocessing are critical stages, not only in predicting DTIs but in every data science project. But such a huge part of a project may not be that simple to overcome. Which including that, both of these stages have their steps to climb, starting with the process of collecting data that have issues such as: Data quality issues, Finding relevant data, Deciding what data to collect, Dealing with huge data environments, Low response (Craig Stedman, 2023).
Meanwhile, for preprocessing, researchers have to deal with challenges like the below: Missing Data, Outliers, Categorical Data, Different Scales, Imbalanced Data, Feature Relevancy, Data Leakage, Time-Series Data Challenges, High-Dimensional Data (Shaik, 2023).
Overcoming challenges in data collection and preprocessing involves implementing strategies to address issues such as incomplete or noisy data, ensuring data quality and consistency, and optimizing data preprocessing techniques to extract meaningful insights from the raw data, thereby enhancing the overall robustness and reliability of subsequent analyses and modeling tasks.
1. Introduction: Discusses the significance of predicting drug-target interactions, the difficulties of traditional discovery methods, and the potential of machine learning to accelerate this field.
2. Literature Review: Provides background on pharmacology and traditional discovery methods while explaining the necessity of computational approaches and an overview of ML techniques.
3. Data Collection and Preprocessing: Details the essential data sources, such as databases for drugs and proteins, and the systematic steps for preparing data for machine learning models.
4. Machine Learning Models: Offers a deep dive into specific algorithms like SVMs, Random Forests, and Neural Networks, explaining their operational principles and suitability for DTI tasks.
5. Evaluation Metrics: Outlines the mathematical and statistical frameworks, including classification and regression metrics, used to assess the performance of the implemented models.
6. Experimental Setup: Explains the objectives and conditions of the experiment, including model training, validation pipelines, and parameter settings.
7. Results: Presents the environment setup for the experiment and showcases the outcomes of applying the Random Forest model on drug-target data.
8. Future Directions: Recommends potential improvements, such as hybrid modeling and the incorporation of more advanced architectures like CNNs and RNNs.
9. Conclusion: Synthesizes the finding that machine learning models significantly enhance DTI prediction and highlights the necessity of high computational resources and data quality.
machine learning, drug-target interactions, drug discovery, dataset, models, predictive modeling, computational biology, feature engineering, classification, neural networks, random forest, bioinformatics, pharmacology, algorithm, data preprocessing
The research focuses on the application of machine learning models to predict how drugs interact with specific biological targets, aiming to improve efficiency in the drug discovery process.
The thesis covers the pharmacological significance of drug-target interactions, the limitations of traditional lab-based discovery, and the practical implementation of machine learning for computational prediction.
The goal is to explore and evaluate the effectiveness of different machine learning algorithms, specifically Random Forests, in predicting DTIs and contributing to more reliable drug development.
The study employs data collection from various biological databases, preprocessing techniques for feature engineering, and the training and evaluation of models like SVMs, Random Forests, and Neural Networks.
The main body examines the entire computational pipeline, from collecting and cleaning data to selecting appropriate models, evaluating them with specific metrics, and presenting the experimental setup.
Key terms include machine learning, drug-target interactions, drug discovery, algorithm, dataset, and bioinformatics.
The study utilizes Random Forest due to its robustness and ability to handle large, complex datasets, demonstrating its effectiveness in feature importance and predictive accuracy.
Databases like DrugBank, ChEMBL, and PubChem serve as essential sources for chemical structures and protein data, providing the foundational information required for model training.
Common challenges include handling missing data, managing outliers, addressing class imbalance, and processing high-dimensional datasets to ensure model robustness.
They provide a comprehensive summary of model classification performance, helping researchers identify how well the model differentiates between interactions and non-interactions.
Der GRIN Verlag hat sich seit 1998 auf die Veröffentlichung akademischer eBooks und Bücher spezialisiert. Der GRIN Verlag steht damit als erstes Unternehmen für User Generated Quality Content. Die Verlagsseiten GRIN.com, Hausarbeiten.de und Diplomarbeiten24 bieten für Hochschullehrer, Absolventen und Studenten die ideale Plattform, wissenschaftliche Texte wie Hausarbeiten, Referate, Bachelorarbeiten, Masterarbeiten, Diplomarbeiten, Dissertationen und wissenschaftliche Aufsätze einem breiten Publikum zu präsentieren.
Kostenfreie Veröffentlichung: Hausarbeit, Bachelorarbeit, Diplomarbeit, Dissertation, Masterarbeit, Interpretation oder Referat jetzt veröffentlichen!

